- Report
- July 2025
- 150 Pages
United States
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- December 2022
- 142 Pages
Global
From €1658EUR$1,899USD£1,441GBP
- Report
- April 2022
- 334 Pages
Global
From €4191EUR$4,799USD£3,641GBP
- Report
- June 2018
- 315 Pages
Global
From €3056EUR$3,499USD£2,655GBP
- Report
- February 2022
- 265 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- December 2021
- 377 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- August 2023
- 172 Pages
Global
From €4061EUR$4,650USD£3,528GBP
- Report
- September 2019
- 119 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- September 2018
- 15 Pages
Global
- Report
- September 2024
- 192 Pages
Global
From €4061EUR$4,650USD£3,528GBP
- Report
- July 2024
- 80 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- December 2023
- 52 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- June 2022
- 55 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- April 2022
- 48 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- December 2022
- 68 Pages
Global
- Report
- August 2024
- 100 Pages
Global
From €4061EUR$4,650USD£3,528GBP
- Report
- June 2023
- 340 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- September 2024
- 323 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- July 2024
- 339 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- September 2024
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more